EUVIMEDEUVIMED entdecken
Crossref

Early outcomes of lung transplantation with lung allografts from coronavirus disease 2019 (COVID-19)–positive donors

Jae Hyun Jeon, Takashi Harano, John C S Rodman, Megha Sheth, Sean C Wightman, Scott M Atay, Anthony W Kim

The Journal of Thoracic and Cardiovascular Surgery · 2024

DOI: 10.1016/j.jtcvs.2023.08.031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Thoracic and Cardiovascular Surgery, 2024. Verfasst von Jae Hyun Jeon und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Thoracic Surgery, Department of Surgery, Keck School of Medicine of the University of Southern California, Los Angeles, Calif; Department…. Hauptthemen laut MEDLINE: Lung Transplantation, COVID-19, Tissue Donors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: NCATS NIH HHS, National Institutes of Health, National Center for Advancing Translational Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Coronavirus disease 2019 (COVID-19) can be detected for extended periods of time with nucleic acid amplification test even after transmissibility becomes negligible. Lung allografts from COVID-19-positive donors have been used for transplantation in highly selected cases. This study aimed to clarify the early outcomes of lung transplantation with COVID-19-positive donors. METHODS: The Organ Procurement and Transplantation Network/United Network for Organ Sharing database between April 2020 and June 2022 was retrospectively analyzed. RESULTS: In the study period, 1297 COVID-19-positive donors were identified and the lungs were transplanted from 47 donors (3.6%). Of 47 donors, 44 donors were positive for COVID-19 NAT with nasopharyngeal swabs and the other 3 were positive with bronchoalveolar lavage. The COVID-19-positive lung donors were younger than the COVID-19-negative donors (28.4 ± 11.6 years vs 35.4 ± 13.6 years, P < .001). Recipients of the COVID-19-positive lungs (n = 47) were more likely have a greater lung allocation score (57.1 ± 22.9 vs 50.5 ± 19.7, P = .057) than recipients of COVID-19-negative lungs (n = 5501). The posttransplant length of hospital stay (39.8 ± 43.6 days vs 30.6 ± 34.5 days, P = .181), need for extracorporeal membrane oxygenation support at 72 hours after transplantation (2.6% [1/38] vs 10.4% [541/5184], P = .18), and 1-year overall survival rate (85.6% vs 87.1%, P = .63) were comparable between the 2 groups. CONCLUSIONS: Carefully selected lung allografts from COVID-19-positive donors had comparable early posttransplant outcomes to lung allografts from COVID-19-negative donors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung TransplantationCOVID-19Tissue DonorsHumansMaleFemaleRetrospective StudiesAdultMiddle AgedSARS-CoV-2Treatment OutcomeAllograftsYoung AdultTime FactorsTissue and Organ ProcurementDonor Selection

Stichwörter der Autor:innen

COVID-19 infectiondonor-to-recipient transmissionlung transplantation

Autor:innen und Institutionen

  • Division of Thoracic Surgery, Department of Surgery, Keck School of Medicine of the University of Southern California, Los Angeles, Calif; Department of Thoracic and Cardiovascular Surgery, Seoul National University Bun…
  • Division of Thoracic Surgery, Department of Surgery, Keck School of Medicine of the University of Southern California, Los Angeles, Calif. Electronic address: Takashi.Harano@med.usc.edu.
  • Biostatistics, Epidemiology, and Research Design, Southern California Clinical and Translational Science Institute, University of Southern California, Los Angeles, Calif.
  • Keck School of Medicine of the University of Southern California, Los Angeles, Calif.
  • Division of Thoracic Surgery, Department of Surgery, Keck School of Medicine of the University of Southern California, Los Angeles, Calif.

Förderung

  • NCATS NIH HHS
  • National Institutes of Health
  • National Center for Advancing Translational Sciences

Zitieren

APA

Jeon, J. H., Harano, T., Rodman, J. C. S., Sheth, M., Wightman, S. C., Atay, S. M., & Kim, A. W. (2024). Early outcomes of lung transplantation with lung allografts from coronavirus disease 2019 (COVID-19)–positive donors. The Journal of Thoracic and Cardiovascular Surgery. https://doi.org/10.1016/j.jtcvs.2023.08.031

Vancouver

Jeon JH, Harano T, Rodman JCS, Sheth M, Wightman SC, Atay SM, et al. Early outcomes of lung transplantation with lung allografts from coronavirus disease 2019 (COVID-19)–positive donors. The Journal of Thoracic and Cardiovascular Surgery. 2024. doi:10.1016/j.jtcvs.2023.08.031

BibTeX
@article{Jeon2024,
  author = {Jeon, Jae Hyun and Harano, Takashi and Rodman, John C S and Sheth, Megha and Wightman, Sean C and Atay, Scott M and Kim, Anthony W},
  title = {Early outcomes of lung transplantation with lung allografts from coronavirus disease 2019 (COVID-19)–positive donors},
  journal = {The Journal of Thoracic and Cardiovascular Surgery},
  year = {2024},
  doi = {10.1016/j.jtcvs.2023.08.031}
}
Kostenlos starten →